U.S. FDA Grants Accelerated Approval For Iovance’s Skin Cancer Therapy
Feb 16 (Reuters) - Iovance Biotherapeutics (IOVA.O), opens new tab said on Friday the U.S. health regulator has granted an accelerated approval for its cell therapy…
Carbon
Vertex, CRISPR’s Gene-Editing Therapy Casgevy Wins Early FDA Nod
he FDA has approved Vertex and CRISPR's gene-editing therapy Casgevy to treat beta thalassemia. Casgevy becomes the first therapy for the rare blood disorder…
Wellness Program RESET: What Employers Should Expect From Vendors
A recent report published by McKinsey estimates that poor health costs the U.S. economy about $3.2 trillion annually from premature deaths and the lost…
Yescarta Receives U.S. FDA Approval
Landmark ZUMA-7 Study Demonstrated Patients on Yescarta Were 2.5 Times More Likely to Be Alive at Two Years Without Cancer Progression or Need for…
